raw materials Ozenoxacin Powder

CAS:245765-41-7

MF:C21H21N3O3

MW:363.41

EINECS:105-745-2

Specification​: 99% min Ozenoxacin

Sample:Ozenoxacin Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance:white

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Ozenoxacin Usage and Synthesis.

Ozefloxacin acts by inhibiting bacterial DNA replicase, DNA cyclase A and topoisomerase IV. Ozefloxacin is the third non-fluoroquinolone antibiotic approved in the world after Nenofloxacin and Garefloxacin. In clinical trials, Ozefloxacin was used to treat skin and soft tissue infections, and the efficacy was superior to mupirocin, with no significant adverse effects. The inhibitory effect of ozefloxacin on MRSA, methicillin-sensitive Staphylococcus aureus (MSSA) and ofloxacin-resistant Staphylococcus aureus was significantly stronger than that of nafloxacin, ofloxacin, levofloxacin, chlorlincomycin, erythromycin and gentamicin. Ozefloxacin has strong bactericidal activity and can be used as a new quinolone with a short course of treatment and a good clinical application prospect.

Uses of Ozenoxacin.

For the treatment of impetigo caused by infection with Staphylococcus aureus or Streptococcus pyogenes in patients aged two months and older.

Preparation of Ozenoxacin.

Product method of Ozenoxacin.